A
Price
$126.78
Change
-$0.41 (-0.32%)
Updated
Sep 17, 04:59 PM (EDT)
Capitalization
35.62B
75 days until earnings call
MTD
Price
$1274.13
Change
-$1.97 (-0.15%)
Updated
Sep 17, 04:58 PM (EDT)
Capitalization
25.96B
50 days until earnings call
Interact to see
Advertisement

A vs MTD

Header iconA vs MTD Comparison
Open Charts A vs MTDBanner chart's image
Agilent Technologies
Price$126.78
Change-$0.41 (-0.32%)
Volume$25.8K
Capitalization35.62B
Mettler-Toledo International
Price$1274.13
Change-$1.97 (-0.15%)
Volume$303
Capitalization25.96B
A vs MTD Comparison Chart in %
Loading...
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
A vs. MTD commentary
Sep 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a StrongBuy and MTD is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 18, 2025
Stock price -- (A: $127.19 vs. MTD: $1276.10)
Brand notoriety: A and MTD are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: A: 102% vs. MTD: 84%
Market capitalization -- A: $35.62B vs. MTD: $25.96B
A [@Medical Specialties] is valued at $35.62B. MTD’s [@Medical Specialties] market capitalization is $25.96B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $10.69B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 0 FA rating(s) are green whileMTD’s FA Score has 1 green FA rating(s).

  • A’s FA Score: 0 green, 5 red.
  • MTD’s FA Score: 1 green, 4 red.
According to our system of comparison, A is a better buy in the long-term than MTD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 5 TA indicator(s) are bullish while MTD’s TA Score has 7 bullish TA indicator(s).

  • A’s TA Score: 5 bullish, 5 bearish.
  • MTD’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, MTD is a better buy in the short-term than A.

Price Growth

A (@Medical Specialties) experienced а +0.74% price change this week, while MTD (@Medical Specialties) price change was -0.72% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +2.37%. For the same industry, the average monthly price growth was +2.95%, and the average quarterly price growth was +17.61%.

Reported Earning Dates

A is expected to report earnings on Dec 01, 2025.

MTD is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Medical Specialties (+2.37% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
A($35.6B) has a higher market cap than MTD($26B). MTD has higher P/E ratio than A: MTD (32.36) vs A (29.72). MTD YTD gains are higher at: 4.284 vs. A (-4.921). A has higher annual earnings (EBITDA): 1.8B vs. MTD (1.22B). A has more cash in the bank: 1.54B vs. MTD (61.8M). MTD has less debt than A: MTD (2.18B) vs A (3.41B). A has higher revenues than MTD: A (6.79B) vs MTD (3.87B).
AMTDA / MTD
Capitalization35.6B26B137%
EBITDA1.8B1.22B148%
Gain YTD-4.9214.284-115%
P/E Ratio29.7232.3692%
Revenue6.79B3.87B176%
Total Cash1.54B61.8M2,484%
Total Debt3.41B2.18B156%
FUNDAMENTALS RATINGS
A vs MTD: Fundamental Ratings
A
MTD
OUTLOOK RATING
1..100
7957
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
100
Overvalued
PROFIT vs RISK RATING
1..100
6970
SMR RATING
1..100
453
PRICE GROWTH RATING
1..100
5358
P/E GROWTH RATING
1..100
4268
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

A's Valuation (52) in the Biotechnology industry is somewhat better than the same rating for MTD (100) in the Medical Specialties industry. This means that A’s stock grew somewhat faster than MTD’s over the last 12 months.

A's Profit vs Risk Rating (69) in the Biotechnology industry is in the same range as MTD (70) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

MTD's SMR Rating (3) in the Medical Specialties industry is somewhat better than the same rating for A (45) in the Biotechnology industry. This means that MTD’s stock grew somewhat faster than A’s over the last 12 months.

A's Price Growth Rating (53) in the Biotechnology industry is in the same range as MTD (58) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

A's P/E Growth Rating (42) in the Biotechnology industry is in the same range as MTD (68) in the Medical Specialties industry. This means that A’s stock grew similarly to MTD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMTD
RSI
ODDS (%)
Bearish Trend 2 days ago
54%
Bearish Trend 2 days ago
62%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
56%
Bullish Trend 2 days ago
55%
Momentum
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
68%
MACD
ODDS (%)
Bearish Trend 2 days ago
65%
Bearish Trend 2 days ago
73%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
62%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bearish Trend 2 days ago
65%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
62%
Declines
ODDS (%)
Bearish Trend 8 days ago
60%
Bearish Trend 8 days ago
61%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
57%
Bullish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
60%
View a ticker or compare two or three
Interact to see
Advertisement
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MTD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
TINY47.710.41
+0.86%
ProShares Nanotechnology ETF
JFLI50.690.06
+0.12%
JPMorgan Flexible Income ETF
XBOC32.740.01
+0.03%
Innovator US Eq Acclrtd 9 Bffr ETF™ Oct
XBB41.400.01
+0.03%
BondBloxx BB Rated USD HY Corp Bd ETF
URNM55.05-2.16
-3.78%
Sprott Uranium Miners ETF